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most significant limitation of these grafts is the com-
plete lack of growth potential of all available patch and
conduit materials. Lesser, but still significant, factors
are their lack of contractility and thrombogenicity.
A viable, autologous, contractile, and less thrombo-
genic bioengineered tissue graft would be ideal for the
surgical repair of congenital cardiac defects. Implanted
as a substitute for the wall of a cardiac chamber or an
artery, the graft should be able to grow and remodel
C ongenital heart disease is an ongoing problem ofsignificant dimension, affecting approximately 1%
of infants.1 Surgical palliation or correction of these
defects may require patch reconstruction of stenotic
lesions or conduit placement for complex congenital
lesions.2 However, all currently available grafts are sub-
ject to material-related failure,3 which is a major con-
tributor to the ongoing morbidity and mortality associ-
ated with a diagnosis of congenital heart disease. The
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with the growth of the child. These tissue-engineered
grafts have the potential to reduce morbidity and mor-
tality rates and improve the quality of life of children
with congenital heart disease. We have previously
reported our experience with the creation of a fetal rat
cardiomyocyte-seeded biodegradable gelatin mesh and
its in vitro and in vivo characteristics after implantation
into the subcutaneous tissue or onto the left ventricular
free wall of adult rats.4 However, construction of these
grafts can be a difficult and time-consuming process,
and the optimal combination of cell types and tech-
nique of seeding for construction of these grafts is
unknown.
We report our initial experience with construction of
a cell-seeded biodegradable polymer scaffold by using
fetal rat ventricular cardiomyocytes, smooth muscle
cells and fibroblasts, and adult human atrial and ven-
tricular cells and our characterization of the rate and
spatial characteristics of growth of these different cell
types within the scaffold. With further development, it
may be possible to use a combination of these cell
types, seeded into a biodegradable mesh, to create a
contractile nonthrombogenic graft that grows and
remodels in the same fashion as the cardiac structure
that it replaces.
Methods
Cell preparation
Fetal rat cell isolation and culture. All animal procedures
were carried out in compliance with the “Guide for the care
and use of laboratory animals” prepared by the Institute of
Laboratory Animal Resources and published by the National
Institutes of Health. Timed, pregnant, inbred Lewis rats
(Charles River, Montreal, Canada) were anesthetized with an
intramuscular injection of ketamine (22 mg/kg body weight)
and killed with an intrathoracic injection of a combination of
sodium pentobarbital and propylene glycol (Euthanyl; 2 mL/
4.25 kg body weight; MTC Pharmaceuticals, Cambridge,
Ontario, Canada). For isolation of ventricular cells, the fetal
rat hearts (19 days’ gestation) were rinsed 3 times with phos-
phate-buffered saline solution (PBS; NaCl 136.9 mmol/L,
KCl 2.7 mmol/L, Na2HPO4 8.1 mmol/L, and KH2PO4 1.5
mmol/L [pH 7.4]). The blood clots, blood vessels, connective
tissue, and atria were removed. The ventricles were rinsed in
PBS 3 times and minced into pieces smaller than 1 mm3 in
size. Fetal rat smooth muscle cells were obtained from the
stomach, and portions of skin were used to obtain fibroblasts.
The tissue was transferred to a tube containing a mixed
enzyme solution (0.2% trypsin, 0.1% collagenase, and 0.02%
glucose) and incubated at 37°C for 20 minutes. The enzyme
solution containing the digested tissue was neutralized with
an equal volume of culture medium (Iscove’s modified
Dulbecco’s medium [IMDM]) supplemented with 10% fetal
bovine serum, 0.1% β-mercaptoethanol (0.1 mmol/L), and
1% penicillin (100 U/mL) and streptomycin (100 µg/mL).5-7
Clumps of cells suspended in solution were dispersed by
repeated pipetting. The cell suspension was centrifuged at
580g for 5 minutes. The supernatant was discarded, and the
cell pellet was resuspended in culture medium. A preplating
technique was used to either enrich or deplete the cell sus-
pension of fibroblasts, taking advantage of their differential
adhesion characteristics. The cell suspension was then divid-
ed into 4 to 6 cell-culture dishes (10 cm in diameter), and
IMDM was added to each of the dishes to a total volume of
11 mL. Cells were cultured at 37°C in 5% CO2 and 95% air.
Cultured cells were identified by immunohistochemistry.
Cultures of fetal rat ventricular cardiomyocytes were stained
with antibodies against troponin I. Purity of the cardiomyo-
cyte culture was 96% ± 3%. Smooth muscle cell cultures
underwent staining with antibodies directed against smooth
muscle cell actin, with a purity of 88% ± 6%. Fibroblast cul-
tures were examined microscopically, and spindle-shaped cells
of the anticipated morphology were presumed to be fibroblasts.
The purity of the fibroblast cultures was 92% ± 5%.
Adult human atrial and ventricular cell isolation and cul-
ture. Adult patients undergoing coronary artery bypass
surgery gave informed consent under a protocol approved by
our institutional research ethics committee and had a small
portion of the right atrial appendage excised for isolation and
culture of atrial cells. A Tru-Cut needle (Allegiance
Healthcare Corporation, McGaw Park, Ill) was also used to
obtain a full-thickness core biopsy specimen of the anterior
wall of the left ventricle in an area of grossly normal-appear-
ing myocardium. Cell preparation, isolation, and culture were
performed5-7 as described for the rat, except that the debris
from the initial digestion was subjected to 2 more cycles of
digestion with trypsin and collagenase. Briefly, the tissue was
digested in enzyme solution (0.2% trypsin, 0.1% collagenase,
and 0.02% glucose) at 37°C for 20 minutes before neutral-
ization with IMDM, containing 10% fetal bovine serum,
0.1% β-mercaptoethanol (0.1 mmol/L), and 1% penicillin
(100 U/mL) and streptomycin (100 µg/mL).5-7 The cell sus-
pension was removed after each cycle, and fresh enzyme
solution was added to the remaining tissue pellet for each
additional cycle. The 3 aliquots of cell suspension were com-
bined, centrifuged, and then resuspended in fresh medium for
culturing. Preplating was used to deplete the cell suspension
of fibroblasts. Cultures were maintained, as previously
described,5-7 and were confluent 2 weeks after seeding and
again 1 week after splitting the initial plates.
Cultures of adult human atrial and ventricular cardiomyo-
cytes were stained with antibodies against troponin I for iden-
tification. The purity of our human atrial cardiomyocyte cul-
tures by this immunohistochemical method was 85% ± 4%,
and that of the ventricular cardiomyocytes was 89% ± 3%.
Cell harvesting for seeding. After isolation, the fetal rat
cardiomyocytes, smooth muscle cells, and fibroblasts were
cultured for 24 hours before use in preparation of the graft.
Human atrial and ventricular cells were passaged 3 to 4 times
before further use. At the time of cell harvesting, the cell cul-
ture medium was discarded, and the dishes were rinsed 3
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times with PBS. Trypsin solution, 1 mL (0.05%), with ethy-
lenediamine tetraacetic acid (2 µL/mL) was added to each of
the dishes. The dishes were placed into the incubator for 2 to
3 minutes. Cell culture medium, 2 mL, was added to the dish-
es to stop the digestion. After being pipetted, the cell suspen-
sion was collected in a 50-mL tube. The cell number was
determined with a cell counter (Coulter Electronics Ltd,
England). The tube containing the cell suspension was cen-
trifuged for 5 minutes at 580g. After removal of the super-
natant, the cell pellet was resuspended in a small volume of
culture medium (4 × 107 cells/mL).
Cell growth curves. Growth curves of cultured cells with-
in the Gelfoam meshes (The Upjohn Company, Kalamazoo,
Mich) were constructed for fetal rat ventricular cells, smooth
muscle cells, fibroblasts, adult human atrial cells, and adult
human ventricular cells. A large Gelfoam mesh was cut into
multiple 4 × 10 × 10–mm segments, each of which was seed-
ed with an identical aliquot of cells, slowly distributing the
cell suspension over the top surface of the Gelfoam cube.
After 30 minutes, 5 mL of culture medium was carefully
added along the side of the patch. Two hours later, more
medium was added to submerge the patch completely. Grafts
were incubated at 37°C in 5% carbon dioxide and 95% air,
and medium was changed every 2 days. At each time point,
Gelfoam grafts were completely digested, and the cells with-
in the graft were counted (n = 2 grafts per time point). Each
graft was washed with PBS and digested with 7 mL of PBS
solution containing 0.1% collagenase (273 U/mg, type II),
stirring until the Gelfoam mesh was completely digested
(about 5 to 8 minutes). When digestion of the Gelfoam mesh
was complete, the reaction was stopped by the addition of 5
mL of culture medium. After centrifugation at 600g for 5
minutes, the pellet was immersed in 1 mL of 0.05% trypsin.
This suspension was incubated for 1 minute at 37°C before
the addition of 9 mL of culture medium. The cell number was
then counted in duplicate with a cell counter (Coulter
Electronics), and the cell growth curve was plotted.
Preparation of patches for cell seeding and histology.
Gelfoam patches of varying dimensions and thicknesses were
created. The patches were (1) 10 × 10 × 4 mm, (2) 15 × 15 ×
2 mm, or (3) 15 × 15 × 1 mm. The patches were presoaked in
culture medium and then compressed on a sterile cloth to
remove excess medium. Each patch was then placed in a 10-
cm culture dish for cell seeding.
Seeding of the Gelfoam patches. Different types of cul-
tured fetal rat cells were seeded into Gelfoam patches by a
variety of techniques to study their 3-dimensional growth
characteristics within the matrix.
Injection method. The cell suspension was injected into the
center of a 10 × 10 × 4–mm Gelfoam patch in a single loca-
tion with a 25-gauge needle.
Onlay and stacking method. The cell suspension was slow-
ly and evenly distributed over the surface of a 15 × 15 ×
1–mm patch. After 1 to 2 weeks of initial culture, 2 to 3
patches were stacked together. The seeded surfaces of the first
and second patches were placed in apposition, and the seed-
ed surface of the third patch was placed against the unseeded
surface of the second patch. These stacked Gelfoam patches
were then cultured together in culture medium.
Double onlay and stacking method. The cell suspension
was distributed over the surface of either a 15 × 15 × 1–mm
patch or a 15 × 15 × 2–mm patch. Two days later, the seeded
patch was flipped over, and the other surface of the patch was
seeded in the same fashion, with an identical number of cells.
After 1 to 2 weeks of initial culture, 2 to 3 of these doubly
seeded patches were stacked together and then cultured
together in a sufficient depth of culture medium to keep the
stack completely submerged.
Histologic analysis. Each graft was washed with PBS and
fixed in a 37% solution of formaldehyde for 2 days. The
grafts were then cut in half along the center of the patch,
embedded in paraffin, and sectioned to yield 10-µm thick
specimens. Sections were stained with hematoxylin and eosin
stain as described in the manufacturer’s specifications (Sigma
Diagnostics, St Louis, Mo).
Results
Growth curves. The growth curves of fetal rat ven-
tricular cardiomyocytes, stomach smooth muscle cells,
skin fibroblasts, and adult human atrial and ventricular
cardiomyocytes within the Gelfoam grafts are present-
ed in Fig 1, A-E. The fetal rat cardiomyocytes and
smooth muscle cells demonstrated steady proliferation
over the course of these experiments. Fetal rat fibro-
blasts also grew gradually within the matrix, but we
noted much more rapid shrinkage and degradation of
the Gelfoam block and gradual and progressive transfer
of the fibroblasts onto the surface of the underlying cul-
ture dish. Adult human atrial cardiomyocytes proliferat-
ed within the Gelfoam patch but at a significantly slow-
er rate than that noted in the fetal rat cardiomyocytes.
Adult human ventricular cardiomyocytes survived with-
in the Gelfoam matrix but did not appear to increase in
number during the 2-week duration of evaluation.
Gelfoam meshes seeded with the fetal rat ventricular
cells exhibited spontaneous rhythmic contractility with
movement of the Gelfoam patch. No such spontaneous
activity was noted, however, in grafts seeded with adult
human atrial or ventricular cardiomyocytes.
Fate of the Gelfoam matrix. The Gelfoam matrix
gradually decreased in size after being seeded with the
varying cell types and maintained in tissue culture.
Four weeks after cell seeding, the Gelfoam matrix was
80% ± 5% of its original surface area, except after
seeding with fetal rat skin fibroblasts, which resulted in
significantly more rapid degradation of the matrix
(50% ± 3%).
Three-dimensional growth characteristics
Injection method. For fetal rat ventricular cardiomyo-
cytes, despite the cells being injected into the center of
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the 4-mm thick Gelfoam patch at both 2 and 6 weeks
after seeding, viable cardiomyocytes were essentially
found only on the upper surface of the Gelfoam block
(Fig 2). The cardiomyocytes had proliferated over the
entire surface area of the patch but were confined to the
uppermost 300 µm of the thickness of the patch. A
small number of viable cells was noted at the center of
the patch near the original injection site, along with
some cellular debris likely representing the remnants of
necrotic cells.
For fetal rat gastric smooth muscle cells, 2 and 6
weeks after injection into the center of the Gelfoam
patch, the smooth muscle cells had also migrated to the
uppermost surface of the patch, where they had prolif-
erated to cover its entire surface area (Fig 3). The depth
of this layer of cells was approximately 300 µm. Again,
a small number of smooth muscle cells and some
necrotic cellular debris was noted in the center of the
patch.
For fetal rat skin fibroblasts, 2 weeks after injection
A
B C
D E
Fig 1. Growth curves of varying cell types after seeding onto a Gelfoam matrix and maintenance in tissue cul-
ture: fetal rat cardiomyocytes (A), fetal rat gastric smooth muscle cells (B), fetal rat skin fibroblasts (C), adult
human atrial cardiomyocytes (D), and adult human ventricular cardiomyocytes (E). All cell types proliferated
after seeding into the Gelfoam matrix except for the adult human ventricular cardiomyocytes, which survived but
did not increase in number. Fetal rat cells proliferated more rapidly than adult human atrial cardiomyocytes.
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of the fibroblast suspension, we noted a 500-µm thick
layer of viable fibroblasts on the uppermost surface of
the patch (Fig 4). Within this layer, we noted several
hair follicle–like structures. As previously described,
the Gelfoam mesh was rapidly degraded by the fibro-
blasts. Six weeks after injection, we noted only a thin
layer of fibroblasts remaining in the center of the patch.
Onlay and stacking method. For fetal rat ventricular
Fig 2. A gelatin mesh (G) 2 weeks after injection of fetal rat ventricular cardiomyocytes into the center of the
mesh. The cardiomyocytes (C) had migrated to the uppermost surface of the mesh to form a layer approximate-
ly 300 µm thick. (Hematoxylin and eosin stain; original magnification 100×.)
Fig 3. A gelatin mesh (G) 2 weeks after injection of fetal rat stomach smooth muscle cells into the center of the
mesh. The smooth muscle cells (C) had migrated to the uppermost surface of the mesh, forming a layer approx-
imately 300 µm in thickness. (Hematoxylin and eosin stain; original magnification 200×.)
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cardiomyocytes, 1 week after the ventricular cardio-
myocytes were delivered onto the surface of 3 Gelfoam
patches and the patches were stacked together, the
uppermost patch showed even, full-thickness growth of
viable cells (Fig 5). The cells in the second and third
Gelfoam patches below, however, were starting to
necrose, with many of the cells demonstrating nuclear
lysis. After 4 weeks in culture, the patches were essen-
tially unchanged, with cardiomyocyte survival noted
almost exclusively in the top patch.
When only 2 patches (each 1 mm in thickness) were
seeded and stacked together, with their seeded surfaces
in apposition, the cells migrated to the uppermost and
lowermost surfaces. Three and four weeks after stack-
ing, very few viable cells remained at the interface of
the 2 patches. The layer of cardiomyocytes on the
uppermost surface of the stacked patches was notice-
ably thicker than the layer on the lowermost surface,
which was in contact with the Petri dish.
Discussion
Tissue engineering and transplantation has been stud-
ied for many years in several organ systems.8-12
However, the development of a tissue-engineered, cell-
seeded graft material with potential applications in
repair of congenital or acquired cardiac defects has
remained a difficult process. Issues that have yet to be
definitively settled include the selection of an appropri-
ate substrate for seeding with viable cells, the source
and optimal combination of cells to be seeded, the tech-
nique by which to ensure that the seeded cells organize
in a manner that is structurally appropriate for the
intended use of the graft, and the short- and long-term
characteristics of these grafts after implantation.13-17
Our laboratory has used a Gelfoam gelatin mesh as a
biodegradable scaffold to support the 3-dimensional
growth of seeded cells. We have previously character-
ized the behavior of these grafts in tissue culture after
seeding with fetal rat ventricular cells and in vivo after
implantation into either the subcutaneous tissue of
adult rats or onto the left ventricular free wall 4 weeks
after myocardial scarring induced by cryoinjury.4
These cells proliferated within the mesh, but only to a
limited degree when maintained in tissue culture,
prompting us to investigate the rate of proliferation and
the 3-dimensional growth characteristics of a variety of
fetal rat and adult human cell types in this gelatin mesh.
We have previously noted variable rates of prolifera-
tion of rat and human cardiomyocytes in a monolayer
on a culture plate.6,18 These cells proliferate to conflu-
ence and then cease further division unless the cultures
are split.6 In the 3-dimensional matrix of Gelfoam
mesh used in our present study, we observed that fetal
rat cardiomyocytes grew steadily over a 4-week period,
Fig 4. A gelatin mesh (G) 2 weeks after injection of a suspension of fetal rat skin fibroblasts into the center of
the mesh. The fibroblasts (C) had formed a layer approximately 500 µm thick on the upper surface of the patch,
in which were noted several hair follicles (arrows). (Hematoxylin and eosin stain, original magnification 100×.)
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as did fetal rat smooth muscle cells and fibroblasts.
Adult human atrial cardiomyocytes also proliferated at
a steady pace, although more slowly than the fetal rat
cells. The adult human ventricular cardiomyocytes sur-
vived within the Gelfoam matrix, but their numbers did
not increase over a 2-week period. The reason for the
different activities of human atrial and ventricular car-
diomyocytes is unclear. We are continuing these exper-
iments and plan to evaluate grafts seeded with car-
diomyocytes obtained from pediatric patients and to
determine the relative effects of donor age on cell pro-
liferation within these grafts.
In this study we noted that even cells delivered by
means of injection in a single bolus into the middle of
a block of Gelfoam mesh preferentially migrated over
the course of a week to the uppermost surface of the
patch. All cell types examined formed a layer on this
uppermost surface, which was consistently 300 to 500
µm in thickness. The depth of this cell layer may have
been due to the limitation of passive diffusion through
the culture medium for delivery of nutrients and
removal of metabolites from these cells. This might
also account for the necrosis of a significant fraction of
the cells injected in one bolus into the center of the
Gelfoam patch.
We noted that the thickness of the layers of fetal rat
cardiomyocytes was approximately 300 µm, somewhat
less than that noted for fibroblasts. We speculate that the
rhythmic contractile activity of the fetal rat cardiomyo-
cytes might have accentuated the limitations of passive
diffusion for metabolic support of these cells, resulting
in a thinner layer of viable cells. Other potential mech-
anisms may, however, also contribute to this limitation
of cell growth. A cell-signaling phenomenon may have
contributed to the cessation of proliferation at 300 to
500 µm, although the mechanism by which this occurs
may differ from the usual process of contact inhibition
noted when these cells are grown in a monolayer.
We are conducting ongoing studies in an attempt to
clarify the determinants of cell proliferation, linkage,
and contractile activity within these biodegradable cell-
seeded gelatin mesh grafts. It may ultimately become
possible to obtain cells from endomyocardial biopsy
specimens in children with congenital heart disease in
whom palliation or repair can be anticipated to require
a prosthetic patch or conduit. Expansion of these cells
in culture and seeding of an appropriately shaped and
sized biodegradable mesh may allow subsequent surgi-
cal implantation of a graft with growth potential and
perhaps lower thrombogenicity, reducing the late mor-
bidity and mortality that follow even initially success-
ful surgical correction of congenital heart disease.
Niklason and colleagues19 have recently reported the
construction of vascular grafts containing smooth mus-
cle cells and endothelial cells that demonstrate promise
for use in peripheral vascular reconstruction. In prelim-
inary experiments we have also successfully implanted
a cardiomyocyte-seeded gelatin mesh graft as a patch
replacement for the right ventricular outflow tract in
rats. Further studies to determine the medium-term fate
of these grafts are continuing.
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Discussion
Dr Yoshiki Sawa (Osaka, Japan). I would like to ask 2
questions. First, how long can these cells survive? How long
can these cells survive in this mesh? And during its survival,
how was the change of the phenotype? Did it change the
phenotype?
Second question, how was the blood supply in the mesh?
Did you check the blood vessels?
Dr Li. We evaluated cell survival and proliferation in vitro
for as long as 14 days, and the cells survived within the graft
during this period. We are currently investigating the possi-
bility of phenotypic changes of these cells in the graft by
using immunohistochemistry and Northern and Western blots
to evaluate contractile protein levels.
Because this is an in vitro study, we did not find blood ves-
sels within the graft in culture. However, our previous studies
have shown blood vessels growing into the grafts when the
cell-seeded grafts were transplanted into the subcutaneous
tissue of adult rats.
Dr Alain F. Carpentier (Paris, France). I have 2 brief
questions. First, you mentioned human heart cells. Were these
cells fetal cells or adult cells?
One problem you could encounter with this technique is
fibroblast proliferation coming from the host. Have you seen
some fibroblast proliferation, or was your time of observation
too short to see that? What do you think about this potential
problem?
Dr Li. The atrial and ventricular cells were isolated from
the myocardium of adult patients. The cells were seeded in
culture dishes at low density, and cardiac muscle cells were
purified and cultured in IMDM medium. There were few
fibroblasts in the culture after purification. Although the
number of these fibroblasts increased with time, in early pas-
sages (<4) most cells in these cultures expressed contractile
proteins, which were identified by using a monoclonal anti-
body against troponin I and appeared to be cardiac muscle
cells. Although the cell number increased in a monolayer in
the culture plates, they did not proliferate further after being
seeded into the grafts. Therefore, myocardial fibroblasts
could not overgrow the graft.
Our immunohistochemical studies demonstrated that these
cells have contractile proteins, although they did not contract.
We believe that stretch may be necessary to induce organiza-
tion of these contractile proteins into myofilaments.
